How tumors make bad blood vessels and stroma

American Journal of Pathology

Volumn 162, Issue 6, 2003, Pages 1747-1757

  Dvorak, Harold F ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; SIGNAL PEPTIDE;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; BLOOD VESSEL PERMEABILITY; CONFERENCE PAPER; CONGENITAL BLOOD VESSEL MALFORMATION; CONNECTIVE TISSUE; CONTROLLED STUDY; EDEMA; GENE EXPRESSION; GUINEA PIG; LYMPH VESSEL ENDOTHELIUM; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SOLID TUMOR; STROMA; THROMBOSIS; TUMOR BLOOD FLOW; ANIMAL; ARTICLE; CELL VACUOLE; CYTOPLASM VESICLE; ELECTRON MICROSCOPY; HUMAN; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; CYTOPLASMIC VESICLES; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MICROSCOPY, ELECTRON; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; VACUOLES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037926778     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64309-X     Document Type: Conference Paper

References (52)

1. Dvorak HF: Tumors: wounds that do not heal: similarities between tumor stroma generation and wound healing. N Engl J Med 1986, 315:1650-1659
2. Dvorak H, Nagy J, Feng D, Dvorak A: Tumor architecture and targeted delivery. Radioimmunotherapy of Cancer. Edited by P Abrams and A Fritzberg. New York, Marcel Dekker, Inc., 2000, pp 107-135
3. Folkman J: Tumor angiogenesis. Adv Cancer Res 1985, 43:175-203
4. Brown LF, Detmar M, Claffey K, Nagy JA, Feng D, Dvorak AM, Dvorak HF: Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. Exs 1997, 79:233-269
5. Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 1999, 237:97-132
6. Warren BA: The vascular morphology of tumors. Tumor Blood Circulation: Angiogenesis, Vascular Morphology and Blood Flow of Experimental and Human Tumors. Edited by H-I Peterson. Boca Raton, FL, CRC Press, Inc., 1979, pp 1-47
7. Dvorak HF, Nagy JA, Dvorak AM: Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies. Cancer Cells 1991, 3:77-85
8. Beck L Jr, D'Amore PA: Vascular development: cellular and molecular regulation. EMBO J 1997, 11:365-373
9. Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000, 6:389-395
10. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J: Vascular-specific growth factors and blood vessel formation. Nature 2000, 407:242-248
11. Dvorak HF, Dvorak AM, Manseau EJ, Wiberg L, Churchill WH: Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs: role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression. J Natl Cancer Inst 1979, 62:1459-1472
12. Dvorak HF, Orenstein NS, Carvalho AC, Churchill WH, Dvorak AM, Galli SJ, Feder J, Bitzer AM, Rypysc J, Giovinco P: Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. J Immunol 1979, 122:166-174
13. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983, 219:983-985
14. Senger DR, Perruzzi CA, Feder J, Dvorak HF: A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 1986, 46:5629-5632
15. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989, 246:1309-1312
16. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989, 84:1470-1478
17. Leung DW, Cachianes G, Kuang W-J, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989, 246:1306-1309
18. Ferrara N, Keyt B: Vascular endothelial growth factor: basic biology and clinical implications. Exs 1997, 79:209-232
19. Veikkola T, Alitalo K: VEGFs, receptors and angiogenesis. Semin Cancer Biol 1999, 9:211-220
20. Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF, Manseau EJ, Dvorak AM, Dvorak HF: VEGF-A induces angiogenesis, arteriogenesis, lymphangiogenesis and vascular malformations. Cold Spring Harbor Symp Quant Biol 2002, 67:227-237
21. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380:435-439
22. Carmeliet P, Ng YS, Nuyens D, Theilmeier G, Brusselmans K, Cornelissen I, Ehler E, Kakkar VV, Stalmans I, Mattot V, Perriard JC, Dewerchin M, Flameng W, Nagy A, Lupu F, Moons L, Collen D, D'Amore PA, Shima DT: Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med 1999, 5:495-502
23. Benjamin LE, Golijanin D, Itin A, Pode D, Keshet E: Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 1999, 103:159-165
24. Watanabe Y, Lee SW, Detmar M, Ajioka I, Dvorak HF: Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells Oncogene 1997, 14:2025-2032
25. Miao HQ, Lee P, Lin H, Soker S, Klagsbrun M: Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. EMBO J 2000, 14:2532-2539
26. Pettersson A, Nagy JA, Brown LF, Sundberg C, Morgan E, Jungles S, Carter R, Krieger JE, Manseau EJ, Harvey VS, Eckelhoefer IA, Feng D, Dvorak AM, Mulligan RC, Dvorak HF: Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest 2000, 80:99-115
27. Dvorak HF, Quay SC, Orenstein NS, Dvorak AM, Hahn P, Bitzer AM, Carvalho AC: Tumor shedding and coagulation. Science 1981, 212:923-924
28. Dvorak HF, Senger DS, Dvorak AM, Harvey VS, McDonagh J: Regulation of extravascular coagulation by microvascular permeability. Science 1985, 227:1059-1061
29. Dvorak HF, Harvey VS, Estrella P, Brown LF, McDonagh J, Dvorak AM: Fibrin-containing gels induce angiogenesis: implications for tumor stroma generation and wound healing. Lab Invest 1987, 57:673-686
30. Dvorak HF, Harvey VS, McDonagh J: Quantitation of fibrinogen influx and fibrin deposition and turnover in line 1 and line 10 guinea pig carcinomas. Cancer Res 1984, 44:3348-3354
31. Kohn S, Nagy JA, Dvorak HF, Dvorak AM: Pathways of macromolecular tracer transport across venules and small veins: structural basis for the hyperpermeability of tumor blood vessels. Lab Invest 1992, 67:596-607
32. Feng D, Nagy JA, Hipp J, Dvorak HF, Dvorak AM: Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. J Exp Med 1996, 183:1981-1986
33. Feng D, Nagy JA, Pyne K, Hammel I, Dvorak HF, Dvorak AM: Pathways of macromolecular extravasation across microvascular endothelium in response to VPF/VEGF and other vasoactive mediators. Microcirculation 1999, 6:23-44
34. Dvorak AM, Kohn S, Morgan ES, Fox P, Nagy JA, Dvorak HF: The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. J Leukoc Biol 1996, 59:100-115
35. Feng D, Nagy JA, Dvorak AM, Dvorak HF: Different pathways of macromolecule extravasation from hyperpermeable tumor vessels. Microvasc Res 2000, 59:24-37
36. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, van de Water L: Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992, 176:1375-1379
37. Swayne GT, Smaje LH: Dynamic compliance of single perfused frog mesenteric capillaries and rat venules: a filtration coefficient correction. Int J Microcirc Clin Exp 1989, 8:43-52
38. Rafii S, Meeus S, Dias S, Hattori K, Heissig B, Shmelkov S, Rafii D, Lyden D: Contribution of marrow-derived progenitors to vascular and cardiac regeneration. Semin Cell Dev Biol 2002, 13:61-67
39. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967
40. Nagy JA, Morgan ES. Herzberg KT, Manseau EJ, Dvorak AM, Dvorak HF: Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining. Cancer Res 1995, 55:376-385
41. Lantos P, VandenBerg S, Kleihues P: Tumors of the nervous system. Greenfield's Neuropathology. Edited by D Graham and P Lantos. London, Arnold, 1997, pp 583-879
42. Sundberg C, Nagy JA, Brown LF, Feng D, Eckelhoefer IA, Manseau EJ, Dvorak AM, Dvorak HF: Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am J Pathol 2001, 158:1145-1160
43. McKee P: Pathology of the skin with clinical correlations. London, Mosby International, 1996, pp 16.57-16.66
44. Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF, Detmar MJ, Lawitts JA, Benjamin L, Tan X, Manseau EJ, Dvorak AM, Dvorak HF: Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 2002, 196:1497-1506
45. Leak LV, Schannahan A, Scully H, Daggett WM: Lymphatic vessels of the mammalian heart. Anat Rec 1978, 191:183-201
46. Feng D, Nagy J, Dvorak H, Dvorak A: Ultrastructural studies define soluble macromolecular, particulate, and cellular transendothelial cell pathways in venules, lymphatic vessels, and tumor-associated microvessels in man and animals. Microsc Res Tech 2002, 57:289-326
47. Brown LF, Lanir N, McDonagh J, Tognazzi K, Dvorak AM, Dvorak HF: Fibroblast migration in fibrin gel matrices. Am J Pathol 1993, 142:273-283
48. Dvorak HF, Form DM, Manseau EJ, Smith BD: Pathogenesis of desmoplasia: I: immunofluorescence identification and localization of some structural proteins of line 1 and line 10 guinea pig tumors and of healing wounds. J Natl Cancer Inst 1984, 73:1195-1205
49. Losordo DW, Vale PR, Isner JM: Gene therapy for myocardial angiogenesis. Am Heart J 1999, 138:132-141
50. Oh SJ, Jeltsch MM, Birkenhager R, McCarthy JE, Weich HA, Christ B, Alitalo K, Wilting J: vEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 1997, 188:96-109
51. Feng D, Nagy JA, Brekken RA, Pettersson A, Manseau EJ, Pyne K, Mulligan R, Thorpe PE, Dvorak HF, Dvorak AM: Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors. J Histochem Cytochem 2000, 48:545-556
52. Jain RK, Fenton BT: Intratumoral lymphatic vessels: a case of mistaken identity or malfunction? J Natl Cancer Inst 2002, 94:417-421